These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 17088493

  • 1. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.
    Stevenson JE, Gay K, Barrett TJ, Medalla F, Chiller TM, Angulo FJ.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):195-7. PubMed ID: 17088493
    [Abstract] [Full Text] [Related]

  • 2. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman M, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
    [Abstract] [Full Text] [Related]

  • 3. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
    Skov R, Matuschek E, Sjölund-Karlsson M, Åhman J, Petersen A, Stegger M, Torpdahl M, Kahlmeter G.
    J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292
    [Abstract] [Full Text] [Related]

  • 4. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
    Nathania I, Nainggolan IM, Yasmon A, Nusatia ACM, Tjoa E, Gunardi WD, Moehario LH.
    BMC Microbiol; 2022 Oct 18; 22(1):250. PubMed ID: 36253712
    [Abstract] [Full Text] [Related]

  • 5. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
    Choi SH, Woo JH, Lee JE, Park SJ, Choo EJ, Kwak YG, Kim MN, Choi MS, Lee NY, Lee BK, Kim NJ, Jeong JY, Ryu J, Kim YS.
    J Antimicrob Chemother; 2005 Dec 18; 56(6):1111-4. PubMed ID: 16244086
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN.
    Microb Drug Resist; 2011 Dec 18; 17(4):551-7. PubMed ID: 21830947
    [Abstract] [Full Text] [Related]

  • 7. Quinolone Resistance Mechanisms Among Salmonella enterica in Malaysia.
    Thong KL, Ngoi ST, Chai LC, Teh CS.
    Microb Drug Resist; 2016 Jun 18; 22(4):259-72. PubMed ID: 26683630
    [Abstract] [Full Text] [Related]

  • 8. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
    Levy DD, Sharma B, Cebula TA.
    Antimicrob Agents Chemother; 2004 Jul 18; 48(7):2355-63. PubMed ID: 15215081
    [Abstract] [Full Text] [Related]

  • 9. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P, Serichantalergs O, Wongstitwilairoong B, Srijan A, Bodhidatta L, Malla S, Mason CJ.
    Southeast Asian J Trop Med Public Health; 2010 Nov 18; 41(6):1416-22. PubMed ID: 21329318
    [Abstract] [Full Text] [Related]

  • 10. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
    Casas MR, Camargo CH, Soares FB, da Silveira WD, Fernandes SA.
    Diagn Microbiol Infect Dis; 2016 May 18; 85(1):85-9. PubMed ID: 26971183
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
    Escribano I, Rodríguez JC, Royo G.
    Int J Antimicrob Agents; 2004 Sep 18; 24(3):300-3. PubMed ID: 15325438
    [Abstract] [Full Text] [Related]

  • 12. Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea.
    Hamidian M, Tajbakhsh M, Tohidpour A, Rahbar M, Zali MR, Walther-Rasmussen J.
    Int J Antimicrob Agents; 2011 Apr 18; 37(4):360-4. PubMed ID: 21371866
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
    Tamang MD, Nam HM, Kim A, Lee HS, Kim TS, Kim MJ, Jang GC, Jung SC, Lim SK.
    Foodborne Pathog Dis; 2011 Nov 18; 8(11):1199-206. PubMed ID: 21877929
    [Abstract] [Full Text] [Related]

  • 14. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
    Marimón JM, Gomáriz M, Zigorraga C, Cilla G, Pérez-Trallero E.
    Antimicrob Agents Chemother; 2004 Oct 18; 48(10):3789-93. PubMed ID: 15388435
    [Abstract] [Full Text] [Related]

  • 15. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct 18; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 16. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among Salmonella Typhi with special reference to GyrB mutations.
    Inayath SB, Broor S, Gupta R, Agarwal P, Majumder S, Anveshi AK, Gaind R.
    J Med Microbiol; 2021 Aug 18; 70(8):. PubMed ID: 34356003
    [Abstract] [Full Text] [Related]

  • 17. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
    Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P.
    J Clin Microbiol; 2005 Nov 18; 43(11):5775-8. PubMed ID: 16272517
    [Abstract] [Full Text] [Related]

  • 18. The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.
    Eibach D, Al-Emran HM, Dekker DM, Krumkamp R, Adu-Sarkodie Y, Cruz Espinoza LM, Ehmen C, Boahen K, Heisig P, Im J, Jaeger A, von Kalckreuth V, Pak GD, Panzner U, Park SE, Reinhardt A, Sarpong N, Schütt-Gerowitt H, Wierzba TF, Marks F, May J.
    Clin Infect Dis; 2016 Mar 15; 62 Suppl 1():S32-6. PubMed ID: 26933017
    [Abstract] [Full Text] [Related]

  • 19. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
    Ray P, Sharma J, Marak RS, Garg RK.
    Indian J Med Res; 2006 Jul 15; 124(1):105-8. PubMed ID: 16926465
    [Abstract] [Full Text] [Related]

  • 20. Functional characterization of quinolone-resistant mechanisms in a lab-selected Salmonella enterica typhimurium mutant.
    Gu Y, Xu X, Lin L, Ren X, Cui X, Hou X, Cui S.
    Microb Drug Resist; 2013 Feb 15; 19(1):15-20. PubMed ID: 23013383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.